NEWS4 April 2014
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
Insight & Strategy
Columnists
Impact magazine is a quarterly publication for MRS members. You can access Impact content on this website.
NEWS4 April 2014
US — IMS Health has priced its initial public offering at $20 a share, which stands to generate $1.3bn for the company and its private equity owners.
The healthcare data firm is putting 52m shares up for sale, with the resulting proceeds – around $1bn – earmarked for paying down existing long-term debt.
Meanwhile, the investment firms that took IMS private in a $5bn deal in 2010 will sell 13m shares – returning $260m to their coffers.
IMS filed for an IPO in January this year. The offering is expected to close on 9 April. Shares are expected to begin trading on the New York Stock Exchange (NYSE) today under the ticker symbol IMS.
Pictured is IMS CEO Ari Bousbib.
UPDATE: IMS shares opened at $22.18 on the NYSE this morning. As of 10.15am ET they were trading at $22.85.
Newsletter
Sign up for the latest news and opinion.
You will be asked to create an account which also gives you free access to premium Impact content.
From the latest @ImpactMRS, a Brexit agreement for data transfers between the UK and the EU was agreed last year –… https://t.co/yTomjwlmsd
Covid-19 communications 'created misunderstanding', finds inquiry https://t.co/pzRds1IB1I #mrx #marketresearch
Stravito launches visual insights tool Atlas https://t.co/0jmpAyaJy9 #mrx #marketresearch
The world's leading job site for research and insight
Hasson Associates
Senior Research Manager / Associate Director
£300–300 per day
Resources Group
Analytics Associate Director – Consumer CX – Key Tech client
£50,000–£60,000 + Bens
Hasson Associates
Associate Director, Technology
£40000–65000
Featured company
Town/Country: London
Tel: +44 (0)20 7490 7888
Kudos Research are leading providers of premium quality UK and International Telephone Data-Collection. Specialising in hard to reach B2B and Consumer audiences, we achieve excellent response rates and provide robust, actionable, verbatim-rich data. Methodologies include CATI, . . .
Town/Country: Aylesbury
Tel: +44 (0)1296 632578
2Europe is an award-winning (Quirk's, RAR Awards), full-service market research agency which specialises in international B2B market research. We are recognised as one of the top market research agencies in the UK . . .
Related Articles
The post-demographic consumerism trend means segments such age are often outdated, from @trendwatching #TrendSemLON
0 Comments